Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
22.73
+0.07 (0.31%)
Nov 14, 2025, 9:36 AM EST - Market open
Stevanato Group Revenue
Stevanato Group had revenue of 303.17M EUR in the quarter ending September 30, 2025, with 9.11% growth. This brings the company's revenue in the last twelve months to 1.17B, up 6.98% year-over-year. In the year 2024, Stevanato Group had annual revenue of 1.10B with 1.72% growth.
Revenue (ttm)
1.17B EUR
Revenue Growth
+6.98%
P/S Ratio
4.50
Revenue / Employee
211,990 EUR
Employees
5,521
Market Cap
6.21B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.10B | 18.68M | 1.72% |
| Dec 31, 2023 | 1.09B | 101.67M | 10.34% |
| Dec 31, 2022 | 983.68M | 139.76M | 16.56% |
| Dec 31, 2021 | 843.92M | 181.88M | 27.47% |
| Dec 31, 2020 | 662.04M | 125.50M | 23.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
STVN News
- 7 days ago - Stevanato Group S.p.A. (STVN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025 - Business Wire
- 14 days ago - Stevanato Group to Participate in Upcoming Investor Conferences - Business Wire
- 23 days ago - Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025 - Business Wire
- 24 days ago - Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings - Business Wire
- 7 weeks ago - Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Stevanato Group S.p.A. (STVN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025 - Business Wire